Publications

Scholarly Journals--Published

  • Daiya KC, Sierra CM. Use of dornase alfa in pediatric patients without cystic fibrosis. Hosp Pract (1995). 2023 Feb 7;1-6. doi: 10.1080/21548331.2023.2176041. (02/2023)
  • Mills K, Hill C, King M, Pauley JL, Cober MP, Fenn NE, Omecene NE, Smith T, Sierra CM. Just DOAC: Use of Direct-acting Oral Anticoagulants in Pediatrics. Am J Health Syst Pharm. 2023 Jan 5;zxac387. doi: 10.1093/ajhp/zxac387. (01/2023)
  • Vyhmeister K, Sierra CM. Codeine prescribing practices before and after the 2017 FDA warning at an academic health system. J Am Pharm Assoc (2003). 2022 Dec 10;S1544-3191(22)00405-8. doi: 10.1016/j.japh.2022.12.009. (12/2022)
  • Sierra CM, Daiya KC. Prophylaxis for Pneumocystis jirovecii pneumonia in patients with inflammatory bowel disease. Pharmacotherapy. 2022 Nov;42(11):858-67. doi: 10.1002/phar.2733. (11/2022)
  • Sierra CM, Tran Y, Oana L, Bahjri K. Renal impairment associated with trimethoprim/sulfamethoxazole use in the pediatric population. J Pediatr Pharmacol Ther. 2022 Sep; 27(1)663-8. doi: 10.5863/1551-6776.27.7.663. (09/2022)
  • Kuriakose J, Kaplansky M, Sierra CM. Myelosuppression rates with administration of nafcillin with and without rifampin in pediatric patients. Pediatr Rep. 2022;14(2):288-92. doi: 10.3390/pediatric14020036. (06/2022)
  • Sierra CM, Koch J, Gonzalez J, Bahjri K. Student perception of academic advising in a school of pharmacy. Int J Pharm Pract. 2022 May 26;30(2):184-7. doi: 10.1093/ijpp/riab083. (05/2022)
  • Bobo KS, Cober MP, Eiland LS, Heigham M, King M, Johnson PN, Miller JL, Sierra CM. Key articles and guidelines for the pediatric clinical pharmacist from 2019-2020. Am J Health Syst Pharm. 2022 Feb 18;79(5):364-84. doi: 10.1093/ajhp/zxab426 (02/2022)
  • Smith C, Sierra CM, Robbins J, Cobbina E. Enteral antipseudomonal fluoroquinolones for ventilator-associated tracheobronchitis in children with pre-existing tracheostomy. Pediatr Pulmonol. 2022 Jan;57(1):1064-71. doi: 10.1002/ppul25816. (01/2022)
  • Awad M, Sierra CM, Mesghali E, Bahjri K. Twice weekly prophylaxis with trimethoprim/sulfamethoxazole for Pneumocystis jirovecii pneumonia in pediatric oncology patients. J Oncol Pharm Pract. 2021 Dec;27(8):1936-9. doi: 10.1177/1078155220979046. (12/2021)

Abstract

  • The Use of Vitamin K for Coagulopathy in Critically Ill ChildrenC Smith, C Sierra, R Valencia, and M LopezAbstract: Society of Critical Care Medicine Critical Care CongressVirtual (04/2022)